
Yazone S 1000mg/500mg Injection
Marketer
Silhos Pharma Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Yazone S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby halting infection spread. Administration of Combiflox 1000mg/500mg Injection must be under strict medical guidance. Consistent adherence to the prescribed regimen is crucial; premature cessation may compromise efficacy. Complete the full course, even with symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical consultation. Allergic reactions (skin rashes, itching, edema, respiratory distress) require urgent medical attention. Inform your physician about all concurrent medications before initiating treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Uses of Yazone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Yazone S 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Yazone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Yazone S 1000mg/500mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Yazone S 1000mg/500mg Injection works:
Ceftriaxone 1000mg and Sulbactam 500mg, combined in Yazone S Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, inhibiting their growth. The beta-lactamase inhibitor, Sulbactam, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Yazone S 1000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Yazone S 1000mg/500mg is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Yazone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended until the maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Yazone S 1000mg/500mg Injection might induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Yazone S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The 1000mg/500mg Yazone S Injection requires careful administration in individuals with advanced liver impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for the 1000mg/500mg Yazone S Injection is unnecessary for patients exhibiting mild or moderate hepatic dysfunction.
What if you forget to take Yazone S 1000mg/500mg Injection :
Should you forget a scheduled Yazone S 1000mg/500mg Injection, seek medical advice immediately.
Facts to Know About Yazone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
